
    
      Test groups: 4 (400 subjects/group). 3 groups receiving 10-valent pneumococcal conjugate
      vaccine (3 different lots) as follows: - 10-valent vaccine (lot 1, 2 or 3) + DTPa combined
      vaccine; Control group receiving Prevenar + DTPa combined vaccine
    
  